DALLAS, August 02, 2023--(BUSINESS WIRE)--Blackboxstocks, Inc. (NASDAQ: BLBX) ("Blackbox"), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders, today announced the launch of its Pro Tier Trading Package that will allow professional traders, financial institutions, and RIA’s to subscribe to the Blackbox… Read More..

First patient dosed in Quoin’s single arm, open label clinical trial in Netherton Syndrome patients currently receiving off-label systemic therapy Recruitment and dosing continue in Quoin’s ongoing double blinded, placebo-controlled study of QRX003 for Netherton Syndrome Following successful public offering Quoin expects its cash runway will extend into 2H 2024… Read More..

TORONTO, Ontario and CAMBRIDGE, Massachusetts, May 08, 2023 (GLOBE NEWSWIRE) -- In preclinical studies, PMN310 demonstrated the ability to selectively target and protect against pathogenic Aβ oligomers The IND clearance of PMN310 in the Alzheimer’s disease indication paves the way for initiation of clinical evaluation ProMIS Neurosciences Inc. (TSX: PMN)… Read More..